Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: Ad26.COV2.S | Statement: [Janssen COVID-19 Vaccine, alsoKnownAs, Ad26.COV2.S]

Target entity: Ad26.COV2.S
Context triple: [Janssen COVID-19 Vaccine, alsoKnownAs, Ad26.COV2.S]

• A. Omicron
  Omicron is a vowel letter of the Greek alphabet, historically representing a short "o" sound and used today in various scientific and mathematical contexts.
• B. rVSV-ZEBOV
  rVSV-ZEBOV is an experimental recombinant vesicular stomatitis virus-based vaccine developed to protect humans against infection by the Zaire strain of the Ebola virus.
• C. Leqembi
  Leqembi is an Alzheimer’s disease drug (lecanemab) that targets amyloid-beta plaques to slow cognitive decline in early-stage patients.
• D. Phage Group
  The Phage Group was an informal collective of mid-20th-century molecular biologists who used bacteriophages to uncover fundamental principles of genetics and helped lay the foundations of molecular biology.
• E. TMV
  TMV is the stock ticker symbol under which TeamViewer, a global provider of remote connectivity and remote access software, is traded on financial markets.
• F. None of above. chosen
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"

Entity: Ad26.COV2.S
Triple: [Janssen COVID-19 Vaccine, alsoKnownAs, Ad26.COV2.S]

Ad26.COV2.S is a single-dose, adenovirus vector-based COVID-19 vaccine developed by Janssen (Johnson & Johnson) to provide protection against SARS-CoV-2 infection.

Target entity: Ad26.COV2.S
Target entity description: Ad26.COV2.S is a single-dose, adenovirus vector-based COVID-19 vaccine developed by Janssen (Johnson & Johnson) to provide protection against SARS-CoV-2 infection.

• A. Omicron
  Omicron is a vowel letter of the Greek alphabet, historically representing a short "o" sound and used today in various scientific and mathematical contexts.
• B. rVSV-ZEBOV
  rVSV-ZEBOV is an experimental recombinant vesicular stomatitis virus-based vaccine developed to protect humans against infection by the Zaire strain of the Ebola virus.
• C. Leqembi
  Leqembi is an Alzheimer’s disease drug (lecanemab) that targets amyloid-beta plaques to slow cognitive decline in early-stage patients.
• D. Phage Group
  The Phage Group was an informal collective of mid-20th-century molecular biologists who used bacteriophages to uncover fundamental principles of genetics and helped lay the foundations of molecular biology.
• E. TMV
  TMV is the stock ticker symbol under which TeamViewer, a global provider of remote connectivity and remote access software, is traded on financial markets.
• F. None of above. chosen